Order For OTC Emergency Contraceptive Access Exceeds Court’s Authority – DoJ
This article was originally published in The Pink Sheet Daily
Executive Summary
A judge will rule May 10 on DoJ’s argument to stay an order that FDA allow OTC sales of all nonprescription emergency contraceptives. DoJ is appealing the order, and argues that without a stay, FDA’s authority would be undermined and Teva would unfairly lose additional market exclusivity for Plan B One-Step.